Lung cancer patients harboring epidermal growth factor receptor mutation among those infected by human immunodeficiency virus

por Okuma, Yusuke, Hosomi, Yukio, Imamura, Akifumi
Publicado 2014

Malignant pleural mesothelioma with resolution of pleural effusion

por Nishida, Sayaka, Toriyama, Kazutoshi, Yomota, Makiko, Hosomi, Yukio
Publicado 2023

Clinical outcome of thymic lymphoepithelioma-like carcinoma: Case report of a 14-year-old male

por SEKIHARA, KUNIKO, OKUMA, YUSUKE, KAWAMOTO, HIROSHI, HOSOMI, YUKIO
Publicado 2014

Small-cell lung cancer with a rare epidermal growth factor receptor gene mutation showing “wax-and-wane” transformation

por Takagi, Yusuke, Nakahara, Yoshiro, Hosomi, Yukio, Hishima, Tsunekazu
Publicado 2013

Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature review

por Hashimoto, Kana, Okuma, Yusuke, Hosomi, Yukio, Hishima, Tsunekazu
Publicado 2016

Switching administration of anti‐PD‐1 and anti‐PD‐L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non‐small cell lung cancer: Case series and...

por Kitagawa, Shingo, Hakozaki, Taiki, Kitadai, Rui, Hosomi, Yukio
Publicado 2020

Intracranial complete response for non‐small‐cell lung cancer patient with negative PD‐L1 expression of the lung using nivolumab

por Kitadai, Rui, Zenke, Yoshitaka, Hishima, Tsunekazu, Hosomi, Yukio
Publicado 2021

Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report

por Terashima, Yuto, Hakozaki, Taiki, Takeuchi, Susumu, Hosomi, Yukio
Publicado 2022

Successful Treatment of ALK-Positive Large-Cell Neuroendocrine Carcinoma of the Lung With Sequential ALK Inhibitors: A Case Report

por Kobayashi, Takayuki, Uehara, Yuji, Watanabe, Kageaki, Hishima, Tsunekazu, Hosomi, Yukio
Publicado 2023

Crucial role of treatment with palliative intent for a patient with advanced thymic carcinoma

por NAGAMATA, MAKOTO, OKUMA, YUSUKE, YAMADA, YUKO, HOSOMI, YUKIO, HISHIMA, TSUNEKAZU
Publicado 2014

Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy

por Okuma, Yusuke, Saito, Makoto, Hosomi, Yukio, Sakuyama, Toshikazu, Okamura, Tatsuru
Publicado 2014

Alectinib for choroidal metastasis in a patient with crizotinib-resistant ALK rearranged positive non-small cell lung cancer

por Okuma, Yusuke, Tanaka, Yuichiro, Kamei, Tina, Hosomi, Yukio, Okamura, Tatsuru
Publicado 2015

Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment

por Kashima, Jumpei, Horio, Hirotoshi, Okuma, Yusuke, Hosomi, Yukio, Hishima, Tsunekazu
Publicado 2016

Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma

por Watanabe, Kageaki, Okuma, Yusuke, Kawai, Shoko, Nagamata, Makoto, Hosomi, Yukio
Publicado 2021

A case of diffuse pulmonary ossification

por Yomota, Makiko, Kamei, Tina, Mirokuji, Kie, Hishima, Tsunekazu, Hosomi, Yukio
Publicado 2021

Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin

por Watanabe, Kageaki, Kitadai, Rui, Kitagawa, Shingo, Toya, Takashi, Hosomi, Yukio
Publicado 2020

Efficacy of first‐line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS , MET , FGFR , RET , BRAF , and HER2 alterations

por Uehara, Yuji, Watanabe, Kageaki, Hakozaki, Taiki, Yomota, Makiko, Hosomi, Yukio
Publicado 2022

Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma

por Okuma, Yusuke, Hosomi, Yukio, Miyamoto, Shingo, Shibuya, Masahiko, Okamura, Tatsuru, Hishima, Tsunekazu
Publicado 2016

Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma

por Okuma, Yusuke, Hosomi, Yukio, Miyamoto, Shingo, Shibuya, Masahiko, Okamura, Tatsuru, Hishima, Tsunekazu
Publicado 2016

A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small ce...

por Kato, Yasuhiro, Okuma, Yusuke, Watanabe, Kageaki, Yomota, Makiko, Kawai, Shoko, Hosomi, Yukio, Okamura, Tatsuru
Publicado 2019